Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for CINV in Malignant Glioma
NCT00636805Phase 2Terminated
- Sponsor
- Duke University
- Start
- May 2008
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Duke University. Started May 2008; status: terminated.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00636805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00636805.